Bio Plus Co., Ltd (KOSDAQ:099430)
4,025.00
-90.00 (-2.19%)
Jul 7, 2026, 12:15 PM KST
Bio Plus Market Cap
Bio Plus has a market cap or net worth of 253.24 billion as of July 6, 2026. Its market cap has decreased by -42.26% in one year.
Market Cap
253.24B
Enterprise Value
308.01B
Revenue
94.42B
Ranking
n/a
PE Ratio
29.61
Stock Price
4,025.00
Market Cap Chart
Since September 27, 2021, Bio Plus's market cap has decreased from 451.40B to 253.24B, a decrease of -43.90%. That is a compound annual growth rate of -11.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 253.24B | -18.19% |
| Dec 30, 2025 | 309.55B | -24.79% |
| Dec 30, 2024 | 411.57B | 4.76% |
| Dec 28, 2023 | 392.88B | -2.28% |
| Dec 29, 2022 | 402.04B | 1.78% |
| Dec 30, 2021 | 395.00B | -12.50% |
| Sep 27, 2021 | 451.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InBody Co.,Ltd | 720.44B |
| WON TECH | 546.44B |
| i-SENS | 459.81B |
| Curexo | 364.32B |
| ToolGen | 325.17B |
| Value Added Technology | 274.06B |
| T&R Biofab | 111.53B |
| DRTECH | 89.49B |